MoneyWorks4Me

Alkem Laboratories informs about quarterly statement on investor complaints

11 Jan 2017 Evaluate

Alkem Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1836.80
Dr. Reddys Labs. 1159.00
Cipla 1353.30
Lupin 2082.15
Zydus Lifesciences 1117.00
View more..